NeurodigitX logo — Because your brain knows more about your health than a blood...

NeurodigitX

Because your brain knows more about your health than a blood or a DNA test

Founded 2018 United States Alpharetta, United States 5 employees Blockchain, Health Care +2

General Information

Company Name NeurodigitX
Founded Year 2018
Location United States Alpharetta, United States
Employees 5
Industries Blockchain, Health Care, Health and Wellness +1
Social

BounceWatch is an independent company data service, not affiliated with NeurodigitX. To contact NeurodigitX, visit neurodigitx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NeurodigitX compare?

A PDF of NeurodigitX and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NeurodigitX soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NeurodigitX

NeurodigitX is a health-focused IoT startup, founded in 2018, aiming to revolutionize healthcare assessments. Their slogan, "Because your brain knows more about your health than a blood or a DNA test," encapsulates their unique approach. The company offers a breakthrough digital inflammatory biomarker platform for chronic and infectious diseases through a platform and device. This enables a mainstream bloodless assessment of inflammation levels. NeurodigitX's focus on analyzing neuronal plasticity aims to detect conditions early, making treatment more effective and affordable. Moreover, it emphasizes proactive healthcare for existing conditions. The company's innovative and ethical digital epidemiology platform brings inclusive and transparent health data into the mainstream. Operating from the United States, NeurodigitX is at the forefront of leveraging technology for impactful healthcare solutions. The latest investment details are currently not available.

Business keywords: IoT in healthcare, Digital biomarker platform, Inflammatory biomarkers, Neuronal plasticity analysis, Proactive healthcare solutions, Blockchain in healthcare, Artificial Intelligence in healthcare, Digital Therapeutics, Health Data Analytics, Neuroscience application in healthcare

No funding data available for NeurodigitX yet.

NeurodigitX Alternatives & Competitors

View All Alternatives
NeurodigitX vs

Pioneering predictive health with the power of Vocal Biomarkers & AI

Non Equity Assistance
1 employees
AI, Digital Health
NeurodigitX vs
Feel Therapeutics
Feel Therapeutics United States

Digital Precision Medicine for Mental Health

Venture round
29 employees
Health Care, Health and Wellness
NeurodigitX vs
Akili
Akili United States

Play your medicine®

Series D
124 employees
Biotechnology, Health Care

FAQ About NeurodigitX

Because your brain knows more about your health than a blood or a DNA test
NeurodigitX was founded in 2018.
NeurodigitX is headquartered in Alpharetta, United States.
NeurodigitX operates in Blockchain, Health Care, Health and Wellness and Mobile. Its work centres on IoT in healthcare, Digital biomarker platform, Inflammatory biomarkers and Neuronal plasticity analysis.
NeurodigitX has approximately 5 employees.
Top alternatives and competitors to NeurodigitX include EVOCAL Health, Feel Therapeutics, Akili, MCG motion capture GmbH, NUTRARTE. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NeurodigitX and EVOCAL Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NeurodigitX, https://bouncewatch.com/company/neurodigitx, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes